Vasospastic Angina and its Contemporary Review of Pathophysiology, Diagnosis and Management
Article Sidebar
Main Article Content
Abstract
Introduction: Nearly half of patients who present with angina have non-obstructed coronary arteries. Patients with chest pain in the absence of obstructive coronary artery disease (CAD) remain a challenge. These patients undergoing invasive coronary angiography do not have epicardial coronary disease obstructive enough to explain these symptoms. This condition is potentially serious and can sometimes trigger severe arrhythmia resulting in ventricular fibrillation and sudden death. However, the pathophysiological mechanisms underlying this phenomenon are incompletely understood, which has resulted in limited therapeutic options for patients afflicted with this condition. This review article provides a comprehensive summary of the underlying pathophysiological mechanisms of VSA and the current therapeutic options. We also appraise the current diagnostic approach in patients with suspected VSA.
Result:
Coronary microvascular tone and subsequently, its blood flow is regulated through various vasodilating and vasoconstricting mechanisms. Coronary endothelial dysfunction and vascular smooth muscle hyperreactivity are proposed mechanism causing coronary artery spams. This may cause transient ST-Elevations, malignant arrhythmias and significant heart blocks. Various non-invasive and invasive exams may identify and differentiate these variant anginas.
Conclusions:
VSA can be diagnosed accurately and safely in the catheter laboratory. The mainstay of management is pharmacological treatment.
Downloads
Article Details
Copyright (c) 2024 Sidhi Laksono, Lidya Pertiwi Suhandoko
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Beltrame, J. F., Crea, F., Kaski, J. C., Ogawa, H., Ong, P., Sechtem, U., Shimokawa, H., & Bairey Merz, C. N. (2015a). International standardization of diagnostic criteria for vasospastic angina. European Heart Journal, ehv351. https://doi.org/10.1093/eurheartj/ehv351
Beltrame, J. F., Crea, F., Kaski, J. C., Ogawa, H., Ong, P., Sechtem, U., Shimokawa, H., & Bairey Merz, C. N. (2015b). International standardization of diagnostic criteria for vasospastic angina. European Heart Journal, ehv351. https://doi.org/10.1093/eurheartj/ehv351 DOI: https://doi.org/10.1093/eurheartj/ehv351
Curry, R. C., Pepine, C. J., Sabom, M. B., & Conti, C. R. (1979). Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation, 59(2), 307–312. https://doi.org/10.1161/01.CIR.59.2.307 DOI: https://doi.org/10.1161/01.CIR.59.2.307
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990). Regulatory Functions of the Vascular Endothelium. New England Journal of Medicine, 323(1), 27–36. https://doi.org/10.1056/NEJM199007053230106 DOI: https://doi.org/10.1056/NEJM199007053230106
Ford, T. J., Rocchiccioli, P., Good, R., McEntegart, M., Eteiba, H., Watkins, S., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., Yii, E., Sidik, N., Harvey, A., Montezano, A. C., Beattie, E., Haddow, L., Oldroyd, K. G., Touyz, R. M., & Berry, C. (2018). Systemic microvascular dysfunction in microvascular and vasospastic angina. European Heart Journal, 39(46), 4086–4097. https://doi.org/10.1093/eurheartj/ehy529 DOI: https://doi.org/10.1093/eurheartj/ehy529
Förstermann, U., & Münzel, T. (2006). Endothelial Nitric Oxide Synthase in Vascular Disease. Circulation, 113(13), 1708–1714. https://doi.org/10.1161/CIRCULATIONAHA.105.602532 DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.602532
Ginsburg, R., Lamb, I. H., Schroeder, J. S., Hu, M., & Harrison, D. C. (1982). Randomized double-blind comparison of nifedipine and isosorbide dinitrate therapy in variant angina pectoris due to coronary artery spasm. American Heart Journal, 103(1), 44–48. https://doi.org/10.1016/0002-8703(82)90527-0 DOI: https://doi.org/10.1016/0002-8703(82)90527-0
Goldberg, S., Reichek, N., Wilson, J., Hirshfeld, J. W., Muller, J., & Kastor, J. A. (1979). Nifedipine in the treatment of prinzmetal’s (variant) angina. The American Journal of Cardiology, 44(5), 804–810. https://doi.org/10.1016/0002-9149(79)90201-7 DOI: https://doi.org/10.1016/0002-9149(79)90201-7
Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2013). (2014). Circulation Journal, 78(11), 2779–2801. https://doi.org/10.1253/circj.CJ-66-0098
Halcox, J. P. J., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M. A., Nour, K. R. A., & Quyyumi, A. A. (2002). Prognostic Value of Coronary Vascular Endothelial Dysfunction. Circulation, 106(6), 653–658. https://doi.org/10.1161/01.CIR.0000025404.78001.D8 DOI: https://doi.org/10.1161/01.CIR.0000025404.78001.D8
Higgins, C. B., Wexler, L., Silverman, J. F., & Schroeder, J. S. (1976). Clinical and arteriographic features of Prinzmetal’s variant angina: Documentation of etiologic factors. The American Journal of Cardiology, 37(6), 831–839. https://doi.org/10.1016/0002-9149(76)90106-5 DOI: https://doi.org/10.1016/0002-9149(76)90106-5
JCS Joint Working Group. (2014). Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2013). Circulation Journal, 78(11), 2779–2801. https://doi.org/10.1253/circj.CJ-66-0098 DOI: https://doi.org/10.1253/circj.CJ-66-0098
Jespersen, L., Abildstrøm, S. Z., Hvelplund, A., & Prescott, E. (2013). Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clinical Research in Cardiology, 102(8), 571–581. https://doi.org/10.1007/s00392-013-0568-z DOI: https://doi.org/10.1007/s00392-013-0568-z
Jespersen, L., Hvelplund, A., Abildstrom, S. Z., Pedersen, F., Galatius, S., Madsen, J. K., Jorgensen, E., Kelbaek, H., & Prescott, E. (2012). Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. European Heart Journal, 33(6), 734–744. https://doi.org/10.1093/eurheartj/ehr331 DOI: https://doi.org/10.1093/eurheartj/ehr331
Kadokami, T., Shimokawa, H., Fukumoto, Y., Ito, A., Takayanagi, T., Egashira, K., & Takeshita, A. (1996). Coronary Artery Spasm Does Not Depend on the Intracellular Calcium Store but Is Substantially Mediated by the Protein Kinase C–Mediated Pathway in a Swine Model With Interleukin-1β In Vivo. Circulation, 94(2), 190–196. https://doi.org/10.1161/01.CIR.94.2.190 DOI: https://doi.org/10.1161/01.CIR.94.2.190
Kandabashi, T., Shimokawa, H., Miyata, K., Kunihiro, I., Kawano, Y., Fukata, Y., Higo, T., Egashira, K., Takahashi, S., Kaibuchi, K., & Takeshita, A. (2000). Inhibition of Myosin Phosphatase by Upregulated Rho-Kinase Plays a Key Role for Coronary Artery Spasm in a Porcine Model With Interleukin-1β. Circulation, 101(11), 1319–1323. https://doi.org/10.1161/01.CIR.101.11.1319 DOI: https://doi.org/10.1161/01.CIR.101.11.1319
Kaski, J.-C., Crea, F., Gersh, B. J., & Camici, P. G. (2018). Reappraisal of Ischemic Heart Disease. Circulation, 138(14), 1463–1480. https://doi.org/10.1161/CIRCULATIONAHA.118.031373 DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.031373
Kaski, J. C., Crea, F., Meran, D., Rodriguez, L., Araujo, L., Chierchia, S., Davies, G., & Maseri, A. (1986). Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation, 74(6), 1255–1265. https://doi.org/10.1161/01.CIR.74.6.1255 DOI: https://doi.org/10.1161/01.CIR.74.6.1255
Kaski, J. C., Maseri, A., Vejar, M., Crea, F., Hackett, D., & Halson, P. (1989). Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. Journal of the American College of Cardiology, 14(6), 1456–1463. https://doi.org/10.1016/0735-1097(89)90382-3 DOI: https://doi.org/10.1016/0735-1097(89)90382-3
KISHIDA, H., OTSU, F., SUZUKI, K., HATA, N., KUSAMA, Y., SUZUKI, T., NEJIMA, J., SAITO, T., & IIDA, N. (1985). Prominent negative u wave in variant angina pectoris. Japanese Heart Journal, 26(6), 885–896. https://doi.org/10.1536/ihj.26.885 DOI: https://doi.org/10.1536/ihj.26.885
KISHIDA, H., TADA, Y., FUKUMA, N., SAITOH, T., KUSAMA, Y., & SANO, J. (1996). Significant Characteristics of Variant Angina Patients with Associated Syncope. Japanese Heart Journal, 37(3), 317–326. https://doi.org/10.1536/ihj.37.317 DOI: https://doi.org/10.1536/ihj.37.317
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., … Clapp, B. (2020a). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407–477. https://doi.org/10.1093/eurheartj/ehz425
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., … Clapp, B. (2020b). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407–477. https://doi.org/10.1093/eurheartj/ehz425 DOI: https://doi.org/10.1093/eurheartj/ehz425
Konst, R. E., Damman, P., Pellegrini, D., Hartzema-Meijer, M. J., van Uden, B. J. C., Jansen, T. P. J., Brandsma, J., Vart, P., Gehlmann, H., Maas, A. H. E. M., van Royen, N., & Elias-Smale, S. E. (2021). Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm. International Journal of Cardiology, 333, 14–20. https://doi.org/10.1016/j.ijcard.2021.02.079 DOI: https://doi.org/10.1016/j.ijcard.2021.02.079
Kuga, T., Shimokawa, H., Hirakawa, Y., Kadokami, Y., Arai, Y., Fukumoto, Y., Kuwata, K., Kozai, T., Egashira, K., & Takeshita, A. (2000). Increased Expression of L-Type Calcium Channels in Vascular Smooth Muscle Cells at Spastic Site in a Porcine Model of Coronary Artery Spasm. Journal of Cardiovascular Pharmacology, 35(5), 822–828. https://doi.org/10.1097/00005344-200005000-00021 DOI: https://doi.org/10.1097/00005344-200005000-00021
Kugiyama, K., Yasue, H., Okumura, K., Ogawa, H., Fujimoto, K., Nakao, K., Yoshimura, M., Motoyama, T., Inobe, Y., & Kawano, H. (1996). Nitric Oxide Activity Is Deficient in Spasm Arteries of Patients With Coronary Spastic Angina. Circulation, 94(3), 266–272. https://doi.org/10.1161/01.CIR.94.3.266 DOI: https://doi.org/10.1161/01.CIR.94.3.266
Kunadian, V., Chieffo, A., Camici, P. G., Berry, C., Escaned, J., Maas, A. H. E. M., Prescott, E., Karam, N., Appelman, Y., Fraccaro, C., Louise Buchanan, G., Manzo-Silberman, S., Al-Lamee, R., Regar, E., Lansky, A., Abbott, J. D., Badimon, L., Duncker, D. J., Mehran, R., … Baumbach, A. (2020). An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. European Heart Journal, 41(37), 3504–3520. https://doi.org/10.1093/eurheartj/ehaa503 DOI: https://doi.org/10.1093/eurheartj/ehaa503
Lablanche, J. M., Bauters, C., McFadden, E. P., Quandalle, P., & Bertrand, M. E. (1993). Potassium channel activators in vasospastic angina. European Heart Journal, 14(suppl B), 22–24. https://doi.org/10.1093/eurheartj/14.suppl_B.22 DOI: https://doi.org/10.1093/eurheartj/14.suppl_B.22
Lanza, G. A. (2003). Increased platelet sodium-hydrogen exchanger activity in patients with variant angina. Heart, 89(8), 935–936. https://doi.org/10.1136/heart.89.8.935 DOI: https://doi.org/10.1136/heart.89.8.935
Lanza, G. A., Pedrotti, P., Pasceri, V., Lucente, M., Crea, F., & Maseri, A. (1996). Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. Journal of the American College of Cardiology, 28(5), 1249–1256. https://doi.org/10.1016/S0735-1097(96)00309-9 DOI: https://doi.org/10.1016/S0735-1097(96)00309-9
Masumoto, A., Mohri, M., Shimokawa, H., Urakami, L., Usui, M., & Takeshita, A. (2002). Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina. Circulation, 105(13), 1545–1547. https://doi.org/10.1161/hc1002.105938 DOI: https://doi.org/10.1161/hc1002.105938
Miyata, K., Shimokawa, H., Higo, T., Yamawaki, T., Katsumata, N., Kandabashi, T., Tanaka, E., Takamura, Y., Yogo, K., Egashira, K., & Takeshita, A. (2000). Sarpogrelate, a Selective 5-HT2A Serotonergic Receptor Antagonist, Inhibits Serotonin-Induced Coronary Artery Spasm in a Porcine Model. Journal of Cardiovascular Pharmacology, 35(2), 294–301. https://doi.org/10.1097/00005344-200002000-00018 DOI: https://doi.org/10.1097/00005344-200002000-00018
Mohri, M., Shimokawa, H., Hirakawa, Y., Masumoto, A., & Takeshita, A. (2003). Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. Journal of the American College of Cardiology, 41(1), 15–19. https://doi.org/10.1016/S0735-1097(02)02632-3 DOI: https://doi.org/10.1016/S0735-1097(02)02632-3
Myerburg, R. J., Kessler, K. M., Mallon, S. M., Cox, M. M., deMarchena, E., Interian, A., & Castellanos, A. (1992). Life-Threatening Ventricular Arrhythmias in Patients with Silent Myocardial Ischemia Due to Coronary Artery Spasm. New England Journal of Medicine, 326(22), 1451–1455. https://doi.org/10.1056/NEJM199205283262202 DOI: https://doi.org/10.1056/NEJM199205283262202
Nakayama, M., Yasue, H., Yoshimura, M., Shimasaki, Y., Kugiyama, K., Ogawa, H., Motoyama, T., Saito, Y., Ogawa, Y., Miyamoto, Y., & Nakao, K. (1999). T −786→C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm. Circulation, 99(22), 2864–2870. https://doi.org/10.1161/01.CIR.99.22.2864 DOI: https://doi.org/10.1161/01.CIR.99.22.2864
Newman, C. M., Maseri, A., Hackett, D. R., El-Tamimi, H. M., & Davies, G. J. (1990). Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine. The American Journal of Cardiology, 66(15), 1070–1076. https://doi.org/10.1016/0002-9149(90)90507-W DOI: https://doi.org/10.1016/0002-9149(90)90507-W
Nishigaki, K., Inoue, Y., Yamanouchi, Y., Fukumoto, Y., Yasuda, S., Sueda, S., Urata, H., Shimokawa, H., & Minatoguchi, S. (2010). Prognostic Effects of Calcium Channel Blockers in Patients With Vasospastic Angina - A Meta-Analysis -. Circulation Journal, 74(9), 1943–1950. https://doi.org/10.1253/circj.CJ-10-0292 DOI: https://doi.org/10.1253/circj.CJ-10-0292
Okumura, K., Yasue, H., Matsuyama, K., Goto, K., Miyag, H., Ogawa, H., & Matsuyama, K. (1988). Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. Journal of the American College of Cardiology, 12(4), 883–888. https://doi.org/10.1016/0735-1097(88)90449-4 DOI: https://doi.org/10.1016/0735-1097(88)90449-4
Ong, P., Athanasiadis, A., Borgulya, G., Vokshi, I., Bastiaenen, R., Kubik, S., Hill, S., Schäufele, T., Mahrholdt, H., Kaski, J. C., & Sechtem, U. (2014). Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries. Circulation, 129(17), 1723–1730. https://doi.org/10.1161/CIRCULATIONAHA.113.004096 DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.004096
Ong, P., Athanasiadis, A., Mahrholdt, H., Borgulya, G., Sechtem, U., & Kaski, J. C. (2012). Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clinical Research in Cardiology, 101(8), 673–681. https://doi.org/10.1007/s00392-012-0442-4 DOI: https://doi.org/10.1007/s00392-012-0442-4
Ong, P., Athanasiadis, A., & Sechtem, U. (2013). Patterns of coronary vasomotor responses to intracoronary acetylcholine provocation. Heart, 99(17), 1288–1295. https://doi.org/10.1136/heartjnl-2012-302042 DOI: https://doi.org/10.1136/heartjnl-2012-302042
Ong, P., Camici, P. G., Beltrame, J. F., Crea, F., Shimokawa, H., Sechtem, U., Kaski, J. C., & Bairey Merz, C. N. (2018). International standardization of diagnostic criteria for microvascular angina. International Journal of Cardiology, 250, 16–20. https://doi.org/10.1016/j.ijcard.2017.08.068 DOI: https://doi.org/10.1016/j.ijcard.2017.08.068
Perera, D., Berry, C., Hoole, S. P., Sinha, A., Rahman, H., Morris, P. D., Kharbanda, R. K., Petraco, R., & Channon, K. (2023a). Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership. Heart, 109(2), 88–95. https://doi.org/10.1136/heartjnl-2021-320718
Perera, D., Berry, C., Hoole, S. P., Sinha, A., Rahman, H., Morris, P. D., Kharbanda, R. K., Petraco, R., & Channon, K. (2023b). Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership. Heart, 109(2), 88–95. https://doi.org/10.1136/heartjnl-2021-320718 DOI: https://doi.org/10.1136/heartjnl-2021-320718
Prinzmetal, M., Kennamer, R., Merliss, R., Wada, T., & Bor, N. (1959a). Angina pectoris I. A variant form of angina pectoris. The American Journal of Medicine, 27(3), 375–388. https://doi.org/10.1016/0002-9343(59)90003-8
Prinzmetal, M., Kennamer, R., Merliss, R., Wada, T., & Bor, N. (1959b). Angina pectoris I. A variant form of angina pectoris. The American Journal of Medicine, 27(3), 375–388. https://doi.org/10.1016/0002-9343(59)90003-8 DOI: https://doi.org/10.1016/0002-9343(59)90003-8
Recio-Mayoral, A., Rimoldi, O. E., Camici, P. G., & Kaski, J. C. (2013). Inflammation and Microvascular Dysfunction in Cardiac Syndrome X Patients Without Conventional Risk Factors for Coronary Artery Disease. JACC: Cardiovascular Imaging, 6(6), 660–667. https://doi.org/10.1016/j.jcmg.2012.12.011 DOI: https://doi.org/10.1016/j.jcmg.2012.12.011
Reriani, M., Raichlin, E., Prasad, A., Mathew, V., Pumper, G. M., Nelson, R. E., Lennon, R., Rihal, C., Lerman, L. O., & Lerman, A. (2010). Long-Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients With Early Atherosclerosis. Circulation, 122(10), 958–966. https://doi.org/10.1161/CIRCULATIONAHA.110.967406 DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.967406
Sara, J. D., Widmer, R. J., Matsuzawa, Y., Lennon, R. J., Lerman, L. O., & Lerman, A. (2015). Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. JACC: Cardiovascular Interventions, 8(11), 1445–1453. https://doi.org/10.1016/j.jcin.2015.06.017 DOI: https://doi.org/10.1016/j.jcin.2015.06.017
Satoh, S., Tomoike, H., Mitsuoka, W., Egashira, S., Tagawa, H., Kuga, T., & Nakamura, M. (1990). Smooth muscles from spastic coronary artery segments show hypercontractility to histamine. American Journal of Physiology-Heart and Circulatory Physiology, 259(1), H9–H13. https://doi.org/10.1152/ajpheart.1990.259.1.H9 DOI: https://doi.org/10.1152/ajpheart.1990.259.1.H9
Shimokawa, H. (2000). Cellular and Molecular Mechanisms of Coronary Artery Spasm. Japanese Circulation Journal, 64(1), 1–12. https://doi.org/10.1253/jcj.64.1 DOI: https://doi.org/10.1253/jcj.64.1
Shimokawa, H., Suda, A., Takahashi, J., Berry, C., Camici, P. G., Crea, F., Escaned, J., Ford, T., Yii, E., Kaski, J. C., Kiyooka, T., Mehta, P. K., Ong, P., Ozaki, Y., Pepine, C., Rimoldi, O., Safdar, B., Sechtem, U., Tsujita, K., … Merz, C. N. B. (2021). Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. European Heart Journal, 42(44), 4592–4600. https://doi.org/10.1093/eurheartj/ehab282 DOI: https://doi.org/10.1093/eurheartj/ehab282
Sinha, A., Rahman, H., & Perera, D. (2020). Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management. Cardiovascular Endocrinology & Metabolism, 10(1), 22–30. https://doi.org/10.1097/XCE.0000000000000223 DOI: https://doi.org/10.1097/XCE.0000000000000223
Tonet, E., Pompei, G., Faragasso, E., Cossu, A., Pavasini, R., Passarini, G., Tebaldi, M., & Campo, G. (2021). Coronary Microvascular Dysfunction: PET, CMR and CT Assessment. Journal of Clinical Medicine, 10(9), 1848. https://doi.org/10.3390/jcm10091848 DOI: https://doi.org/10.3390/jcm10091848
Toyo-oka, T., Aizawa, T., Suzuki, N., Hirata, Y., Miyauchi, T., Shin, W. S., Yanagisawa, M., Masaki, T., & Sugimoto, T. (1991). Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation, 83(2), 476–483. https://doi.org/10.1161/01.CIR.83.2.476 DOI: https://doi.org/10.1161/01.CIR.83.2.476
Yamamoto, H., Yoshimura, H., Noma, M., Kai, H., Suzuki, S., Tajimi, T., Sugihara, M., & Kikuchi, Y. (1992). Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P. American Heart Journal, 123(2), 298–303. https://doi.org/10.1016/0002-8703(92)90638-C DOI: https://doi.org/10.1016/0002-8703(92)90638-C
YASUE, H., & KUGIYAMA, K. (1997). Coronary Spasm: Clinical Features and Pathogenesis. Internal Medicine, 36(11), 760–765. https://doi.org/10.2169/internalmedicine.36.760 DOI: https://doi.org/10.2169/internalmedicine.36.760
Yasue, H., Nakagawa, H., Itoh, T., Harada, E., & Mizuno, Y. (2008). Coronary artery spasm—Clinical features, diagnosis, pathogenesis, and treatment. Journal of Cardiology, 51(1), 2–17. https://doi.org/10.1016/j.jjcc.2008.01.001 DOI: https://doi.org/10.1016/j.jjcc.2008.01.001